Glow Lifetech Corp., a biotechnology company, focuses on producing nutraceutical and cannabinoid-based products. The company engages in the commercialization of plant-based MyCell technology delivery system; water-soluble ingredients; customized blends; powder-based Capsules, and market-ready products, as well as precision-dosed capsules. It has exclusive North American rights for the production, sale, and distribution rights for the certain micellization technology for cannabis and hemp derived ingredients, curcumin, vitamin K and iron. The company also engages in the business of secondary processing of ingredients to produce micellized materials from certain vitamins, nutraceuticals, and cannabis extracts that makes fat-soluble substances available for immediate absorption into the body reach near 100% bioavailability and water compatibility. It provides its products under MOD and .decimal brands. Glow Lifetech Corp. was incorporated in 1988 and is headquartered in Etobicoke, Canada.
Metrics to compare | GLOW | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipGLOWPeersSector | |
---|---|---|---|---|
P/E Ratio | −3.4x | −0.4x | −0.5x | |
PEG Ratio | −0.20 | 0.00 | 0.00 | |
Price/Book | 3.4x | 0.9x | 2.6x | |
Price / LTM Sales | 7.3x | 0.7x | 3.3x | |
Upside (Analyst Target) | - | 12.1% | 40.3% | |
Fair Value Upside | Unlock | 23.8% | 5.1% | Unlock |